Pain Therapeutics (Nasdaq: PTIE) has expanded its pipeline with the addition of FENROCK, an early-stage drug candidate. FENROCK is a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE